Validation Institute, the definitive organization for independently validating the health outcomes and savings claims of healthcare solution providers, announced a new innovation aimed at saving time ...

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

As 2025 begins, we would like to reflect on last year’s regulatory developments in the biologics and biosimilars space. Here are ...

2025 promises to be a tumultuous year for the American healthcare and pharma sector. Increased scrutiny on pricing and the ...

Chromatin Bioscience is pleased to announce its ongoing collaboration with EsoBiotec, which has successfully advanced its ESO-T01 in vivo CAR-T candidate into clinical trials. ESO-T01 is the first in ...

Another emerging trend that's preventing the market from realizing the savings possible through biosimilar adoption is the increase in PBM "private label" manufacturing of biosimilars. Companies ...

While financial assets generally were strong in the third quarter, volatility trended higher as markets continued to be ...

What's on the horizon for the life sciences industry? Robin Johnson, PharmD, Gene Therapy Submissions Lead, inSeption Group What unique challenges do gene therapy submissions face compared to ...

A YEAR OF IMPEACHMENT HEARINGS about nothing had amounted to exactly nothing by the time former FBI informant Alexander ...

The S&P 500 plunged 3% on Wednesday, Dec. 18, 2024, as the Fed cut interest rates but struck a cautious tone about future policy moves.

It would also prohibit a PBM from making payments to a pharmacy ... It also authorizes the Health Policy Commission to assess pharmaceutical manufacturing companies and PBMs.

Also, healthcare companies that own pharmacy benefit management units retreated Tuesday ... weaker than expectations of +0.4% m/m. US Nov manufacturing production rose +0.2% m/m, weaker than ...